NCT07606547 Biomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease
| NCT ID | NCT07606547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Muenster |
| Condition | Parkinson's Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-06 |
| Primary Completion | 2028-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-06 with a primary completion date of 2028-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this non-randomized intervention study is to investigate the detailed effects of a structured four-week EMST® training program on the biomechanics of swallowing function in dysphagic Parkinson's patients. A combination of fiberoptic endoscopic evaluation of swallowing (FEES) and pharyngeal high-resolution manometry (HRM) will be employed to comprehensively evaluate the neuromuscular changes in swallowing.
Eligibility Criteria
Inclusion Criteria: * diagnosis of Parkinson's disease, * PD-related dysphagia as objectively diagnosed with FEES Exclusion Criteria: * severe dementia, not able to give consent * dysphagia related to other diagnoses
Contact & Investigator
Sonja Suntrup-Krueger, Prof. Dr. med.
STUDY CHAIR
University Hospital Münster, Department of Neurology, Albert-Schweitzer-Campus 1, A1, 48149 Münster, Germany
Frequently Asked Questions
Who can join the NCT07606547 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07606547 currently recruiting?
Yes, NCT07606547 is actively recruiting participants. Contact the research team at sonja.suntrup-krueger@ukmuenster.de for enrollment information.
Where is the NCT07606547 trial being conducted?
This trial is being conducted at Münster, Germany.
Who is sponsoring the NCT07606547 clinical trial?
NCT07606547 is sponsored by University Hospital Muenster. The principal investigator is Sonja Suntrup-Krueger, Prof. Dr. med. at University Hospital Münster, Department of Neurology, Albert-Schweitzer-Campus 1, A1, 48149 Münster, Germany. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.